Janumet 50 Mg/1000 Mg
$28 – $79
|Sitagliptin / Metformin
|MSD Pharmaceuticals India Pvt Ltd
|Price Per Unit
|Add To Cart
Janumet 50 Mg/1000 Mg
Janumet 50 Mg/1000 Mg is a medicine used in the treatment of type 2 diabetes mellitus. It provides better control of blood sugar when single therapy is not effective and reduces both fasting and postmeal sugar levels. It should be used along with a proper diet and exercise for maximum effect. Monitor your blood sugar level regularly while you are taking Janumet 50 Mg/1000 Mg as it may cause hypoglycemia (low blood sugar level) as a side effect.
Drug =Sitagliptin+ Metformin
Strength = 50 Mg + 1000 Mg
Manufacture= MSD Pharmaceuticals Pvt Ltd
How to Take
Take Janumet 50 Mg/1000 Mgin the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it Janumet 50 Mg/1000 Mg is to be taken with food.
Janumet 50 Mg/1000 Mg Tablet
Janumet 50 Mg/500 Mg Tablet
Janumet XR CP Tablet
Nausea and vomiting
Belching and Heartburn
Janumet 50 Mg/1000 Mg is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking Janumet 50 Mg/1000 Mg medicine.
Janumet 50 Mg/1000 Mg is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may prescribe a safer alternative based on your clinical condition.
Janumet 50 Mg/1000 Mg is not recommended for use in children and adolescents since the safety and efficacy of use are not clinically established.
Janumet 50 Mg/1000 Mg should be used with caution due to the increased risk of bullous pemphigoid, a hypersensitivity reaction of the skin. Any unusual symptoms such as skin blisters or skin rashes should be reported to the doctor on priority. Therapy with the medicine may be discontinued based on the clinical condition of the patient.
Janumet 50 Mg/1000 Mg is not recommended for use in patients with a known history of diabetic ketoacidosis due to the increased risk of worsening of the patient’s condition.